Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant therapy in melanoma.

S Whittaker1

  • 1Skin Tumour Unit, St John's Institute of Dermatology, St Thomas' Hospital, London, UK.

Clinical and Experimental Dermatology
|October 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome.

Bone marrow transplantation·2024
Same author

Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

The British journal of dermatology·2020
Same author

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

The British journal of dermatology·2020
Same author

Violaceous facial nodules.

Clinical and experimental dermatology·2020
Same author

What is going on in your hospital? Use of a non-sterile shampoo cap in neurosurgery.

The Journal of hospital infection·2020
Same author

A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach.

Diabetic medicine : a journal of the British Diabetic Association·2020

Melanoma is an immunologic tumor requiring effective adjuvant therapy for advanced stages. Research is exploring various biotherapies and biochemotherapies, alongside improved staging methods, to enhance patient survival and treatment outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Medical Research

Background:

  • Melanoma exhibits immunologic characteristics, including clinical regression and dormancy.
  • Cytotoxic responses against tumor peptides are present in melanoma.
  • Advanced melanoma (regional nodal or metastatic) shows poor prognosis and chemoresistance, necessitating adjuvant therapies.

Purpose of the Study:

  • To address the urgent need for effective adjuvant therapy in melanoma.
  • To evaluate various therapeutic agents and treatment regimens for melanoma.
  • To improve patient stratification for clinical trials through accurate staging.

Main Methods:

  • Assessment of diverse therapeutic agents, including high-dose interferon.
  • Evaluation of biotherapies and biochemotherapy regimes in phase II and III studies.

Related Experiment Videos

  • Utilization of sentinel lymph node biopsy for accurate melanoma staging.

    • Main Results:

    • High-dose interferon showed initial promise in improving overall survival, but subsequent studies yielded conflicting results.
    • Ongoing phase II and III studies are evaluating various biotherapies and biochemotherapies.
    • Sentinel lymph node biopsy enables accurate staging for patient stratification.

    Conclusions:

    • Despite challenges with some therapies like high-dose interferon, research into biotherapies and biochemotherapies continues.
    • Accurate staging via sentinel lymph node biopsy is crucial for stratifying patients into appropriate clinical trials.
    • The immunologic nature of melanoma underscores the importance of developing novel adjuvant treatment strategies.